Cytosorbents Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cytosorbents Corp.
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Cytosorbents Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cytosorbents Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cytosorbents Corp. is CTSO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cytosorbents Corp. has its primary listing on NASDAQ. You can trade Cytosorbents Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cytosorbents Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cytosorbents Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cytosorbents Corp..